A High Relaxivity Magnetic Resonance Imaging Contrast Agent Targeted to Serum Albumin
Keyword(s):
EP-647 is a serum albumin-targeted magnetic resonance imaging contrast agent comprising a GdDTPA (DTPA, diethylenetriaminepentaacetate) chelate for magnetic resonance signal generation linked via a phosphodiester to a substituted biphenyl for albumin targeting. Albumin binding and relaxivity are higher than the benchmark magnetic resonance angiographic agent MS-325. EP-647 binds primarily to a unique site on serum albumin that is different from the MS-325 site and the binding sites of other drugs.
2019 ◽
Vol 43
(2)
◽
pp. 350-357
◽
2014 ◽
Vol 641
(3-4)
◽
pp. 578-585
◽
2000 ◽
2011 ◽
Vol 46
(7)
◽
pp. 441-449
◽
2021 ◽
Vol 49
(8)
◽
pp. e21141-e21150
1992 ◽
Vol 27
(Supplement 1)
◽
pp. S22
◽
2002 ◽
Vol 9
(9)
◽
pp. 1027-1032
◽
2008 ◽
Vol 14
(3)
◽
pp. 987-995
◽